Bal Pharma Announcements
Trading Window Closure from 1st January 2026 to 16th February 2026- for announcing unaudited financial results for the quarter ended 31.12.2025.
23 Dec, 2025 | 12:49pm • Source: BSE
We are submitting to the exchanges, news paper advertisements of the unaudited standalone and consolidated financial results of the company for the quarter ended 30.09.2029...
17 Nov, 2025 | 04:17pm • Source: BSE
Unaudited standalone and Consolidated financial results for the quarter ended 30.09.2025.
12 Nov, 2025 | 06:56pm • Source: BSE
Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed...
12 Nov, 2025 | 06:49pm • Source: BSE
Clarification on the outcome of the board meeting held on 11.08.2025.
07 Nov, 2025 | 03:00pm • Source: BSE
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...
04 Nov, 2025 | 04:44pm • Source: BSE
Compliance Certificate for the quarter ended 30.09.2025, as per SEBI(PIT) Regulations,2015
24 Oct, 2025 | 12:28pm • Source: NSE
Confirmation as per Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 30.09.2025.
06 Oct, 2025 | 12:11pm • Source: BSE
Completion of term of Mr.H.S Venkatesh ( DIN # 01776040) as Independent Director of the Company.
30 Sep, 2025 | 03:12pm • Source: BSE
Trading Window on dealing with the securities of the Company will be closed from 1st October 2025 until 48 hours of announcement of Unaudited financial...
26 Sep, 2025 | 04:18pm • Source: BSE
Outcome of the 38th Annual General Meeting of the Company.
25 Sep, 2025 | 03:41pm • Source: BSE
Newpaper Publication for Notice for the 38th Annual General Meeting of the Company together with e-voting and Book closure .
03 Sep, 2025 | 04:13pm • Source: BSE
We are submitting the Copy of the unabridged Annual Report, for the financial year ended 31.03.2025.
02 Sep, 2025 | 03:26pm • Source: BSE
Newpaper Publication of the Unaudited financial results for the quarter ended 30.06.2025.
13 Aug, 2025 | 05:00pm • Source: BSE
The Board of Directors at their meeting held on 11.08.2025 has fixed 18th September 2025 as record date for the payment of dividend for the...
12 Aug, 2025 | 05:38pm • Source: BSE
Unaudited financial results ( Standalone and consolidated ) for the quarter ended 30.06.2025.
11 Aug, 2025 | 06:09pm • Source: BSE
Board of Directors of the Company has met today and inter alia transacted the following business,1. Approved the unaudited financial results ( standalone and consolidated...
11 Aug, 2025 | 06:04pm • Source: BSE
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and...
29 Jul, 2025 | 04:47pm • Source: BSE
We are submitting to the exchanges newspaper advertisements of the notice issued to the shareholders regarding transfer of their shares to IEPF account , whose...
10 Jul, 2025 | 05:22pm • Source: BSE
Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
03 Jul, 2025 | 03:06pm • Source: NSE